These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 990576)

  • 1. [Drug therapy of early-childhood minimal brain damage].
    Zueblin W
    Bull Schweiz Akad Med Wiss; 1976 Jul; 32(1-3):141-6. PubMed ID: 990576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychiatry of minimal, early-childhood brain damage].
    Corboz RJ
    Bull Schweiz Akad Med Wiss; 1976 Jul; 32(1-3):75-90. PubMed ID: 990584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methylphenidat (Ritalin) as a psychotropic drug in children with minimal brain dysfunction and epilepsy].
    Kind CR
    Schweiz Med Wochenschr; 1975 Feb; 105(7):213-9. PubMed ID: 1121668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy of minimal brain dysfunction syndrome (clinical study using Captagon)].
    Mangold B
    Prax Kinderpsychol Kinderpsychiatr; 1975 Jul; 24(5):185-90. PubMed ID: 1187555
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacotherapy of attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term treatment with psychoverlan in children and adolescents with behavior disorders].
    Heinze H
    Fortschr Med; 1978 Aug; 96(32):. PubMed ID: 680616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.
    Torres AR; Whitney J; Gonzalez-Heydrich J
    Epilepsy Behav; 2008 Feb; 12(2):217-33. PubMed ID: 18065271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
    National Toxicology Program
    NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychopathology and therapy of minimal brain dysfunction in childhood and adolescence].
    Corboz RJ
    Ther Umsch; 1977 Jan; 34(1):6-14. PubMed ID: 841511
    [No Abstract]   [Full Text] [Related]  

  • 15. Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children.
    Findling RL; Biederman J; Wilens TE; Spencer TJ; McGough JJ; Lopez FA; Tulloch SJ;
    J Pediatr; 2005 Sep; 147(3):348-54. PubMed ID: 16182674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In the long run...longitudinal studies of psychopathology in children. Committee on Child Psychology. Group for the Advancement of Psychiatry. Report no.143.
    Rep Group Adv Psychiatry (1984); 1999; (143):1-183. PubMed ID: 10230287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment.
    Wernicke JF; Adler L; Spencer T; West SA; Allen AJ; Heiligenstein J; Milton D; Ruff D; Brown WJ; Kelsey D; Michelson D
    J Clin Psychopharmacol; 2004 Feb; 24(1):30-5. PubMed ID: 14709944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ritalin: a stimulating drug in the treatment of children with minimal brain dysfunction (MBD)].
    Flapper BC; Koopman HM; Heltzel A
    Tijdschr Kindergeneeskd; 1989 Feb; 57(1):14-20. PubMed ID: 2711365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.